579 related articles for article (PubMed ID: 28545383)
1. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
Khan NA; Khan I; Abid SMA; Zaib S; Ibrar A; Andleeb H; Hameed S; Iqbal J
Med Chem; 2018; 14(1):74-85. PubMed ID: 28545383
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents.
Carradori S; Ortuso F; Petzer A; Bagetta D; De Monte C; Secci D; De Vita D; Guglielmi P; Zengin G; Aktumsek A; Alcaro S; Petzer JP
Eur J Med Chem; 2018 Jan; 143():1543-1552. PubMed ID: 29126727
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Sang Z; Pan W; Wang K; Ma Q; Yu L; Liu W
Bioorg Med Chem; 2017 Jun; 25(12):3006-3017. PubMed ID: 28487125
[TBL] [Abstract][Full Text] [Related]
4. Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study.
Krátký M; Vu QA; Štěpánková Š; Maruca A; Silva TB; Ambrož M; Pflégr V; Rocca R; Svrčková K; Alcaro S; Borges F; Vinšová J
Bioorg Chem; 2021 Nov; 116():105301. PubMed ID: 34492558
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
[TBL] [Abstract][Full Text] [Related]
6. Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ
Plazas E; Hagenow S; Avila Murillo M; Stark H; Cuca LE
Bioorg Chem; 2020 May; 98():103722. PubMed ID: 32155491
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
[TBL] [Abstract][Full Text] [Related]
8. Cyanobiphenyls: Novel H
Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M
Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977
[TBL] [Abstract][Full Text] [Related]
9. Exploration of a Library of 3,4-(Methylenedioxy)aniline-Derived Semicarbazones as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase: Design, Synthesis, and Evaluation.
Tripathi RK; Rai GK; Ayyannan SR
ChemMedChem; 2016 Jun; 11(11):1145-60. PubMed ID: 27135466
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of new pyrazolone Schiff bases as monoamine oxidase and cholinesterase inhibitors.
Tok F; Koçyiğit-Kaymakçıoğlu B; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Bioorg Chem; 2019 Mar; 84():41-50. PubMed ID: 30481645
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities.
Takao K; Toda K; Saito T; Sugita Y
Chem Pharm Bull (Tokyo); 2017; 65(11):1020-1027. PubMed ID: 29093288
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
[TBL] [Abstract][Full Text] [Related]
13. Selected 1,3-Benzodioxine-Containing Chalcones as Multipotent Oxidase and Acetylcholinesterase Inhibitors.
Jeong GS; Kaipakasseri S; Lee SR; Marraiki N; Batiha GE; Dev S; Palakkathondi A; Kavully FS; Gambacorta N; Nicolotti O; Mathew B; Kim H
ChemMedChem; 2020 Dec; 15(23):2257-2263. PubMed ID: 32924264
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
Bolea I; Juárez-Jiménez J; de Los Ríos C; Chioua M; Pouplana R; Luque FJ; Unzeta M; Marco-Contelles J; Samadi A
J Med Chem; 2011 Dec; 54(24):8251-70. PubMed ID: 22023459
[TBL] [Abstract][Full Text] [Related]
15. Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors.
Tzvetkov NT; Stammler HG; Georgieva MG; Russo D; Faraone I; Balacheva AA; Hristova S; Atanasov AG; Milella L; Antonov L; Gastreich M
Eur J Med Chem; 2019 Oct; 179():404-422. PubMed ID: 31265934
[TBL] [Abstract][Full Text] [Related]
16. Deep eutectic solvent mediated synthesis of 3,4-dihydropyrimidin-2(1H)-ones and evaluation of biological activities targeting neurodegenerative disorders.
Saleem Khan M; Asif Nawaz M; Jalil S; Rashid F; Hameed A; Asari A; Mohamad H; Ur Rehman A; Iftikhar M; Iqbal J; Al-Rashida M
Bioorg Chem; 2022 Jan; 118():105457. PubMed ID: 34798458
[TBL] [Abstract][Full Text] [Related]
17. Sulfonyl thioureas with a benzo[d]thiazole ring as dual acetylcholinesterase/butyrylcholinesterase and human monoamine oxidase A and B inhibitors: An in vitro and in silico study.
Dinh Thanh N; Son Hai D; Ngoc Toan V; Thi Kim Van H; Thi Kim Giang N; Minh Tri N
Arch Pharm (Weinheim); 2024 May; 357(5):e2300557. PubMed ID: 38321839
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Tan Z
Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
[TBL] [Abstract][Full Text] [Related]
19. Cholinesterase Inhibitory Activities of Selected Halogenated Thiophene Chalcones.
Parambi DGT; Aljoufi F; Murugaiyah V; Mathew GE; Dev S; Lakshminarayanan B; Hendawy OM; Mathew B
Cent Nerv Syst Agents Med Chem; 2019; 19(1):67-71. PubMed ID: 30451121
[TBL] [Abstract][Full Text] [Related]
20. Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations.
Sasidharan R; Eom BH; Heo JH; Park JE; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Manju SL; Mathew B; Kim H
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):188-197. PubMed ID: 33430657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
